Last reviewed · How we verify

NCT03319225

Examining the Distal Gut Microbiome After Spinal Cord Injury

Completed Last updated 9 October 2018
What this trial tests

trial in Spinal Cord Injury in 5 participants. Completed in 9 January 2018.

Timeline
18 December 2017
Primary endpoint
9 January 2018
9 January 2018

Quick facts

Lead sponsorUniversity of Miami
StatusCompleted
Study typeOBSERVATIONAL
Enrollment5
Start date18 December 2017
Primary completion9 January 2018
Estimated completion9 January 2018
Sites1 location across United States

Conditions studied

Sponsor

University of Miami

Who can join

18 and older, any sex, with Spinal Cord Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to learn more about the causes of gastrointestinal dysfunction after spinal cord injury. It has been thought that the microbiome (the community of bacteria in the body) may be one such cause. The study will examine whether changes in the distal gut microbiome are related to gastrointestinal dysfunction in persons with Spinal Cord Injury and Non-Disabled Controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injury

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03319225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing